Furthermore, assaying human lung tissue revealed that in the clinical samples there was also no increase in NF-κB pathway activation in the COPD lung, suggesting that our pre-clinical data is translational to human disease. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.